As of Jun 29
| -0.20 / -2.97%|
The 5 analysts offering 12-month price forecasts for Genesis Healthcare Inc have a median target of 8.00, with a high estimate of 11.00 and a low estimate of 7.50. The median estimate represents a +22.51% increase from the last price of 6.53.
The current consensus among 5 polled investment analysts is to Hold stock in Genesis Healthcare Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.